• In late February 2026, American Healthcare REIT, Inc. reported fourth-quarter and full-year 2025 results showing higher revenue of US$604.08 million for the quarter and US$2.26 billion for the year, a swing to net income of US$10.78 million for Q4 and US$69.81 million for 2025, and sharply lower real estate impairment charges.
• At the same time, the company launched and began using a new US$1.75 billion at-the-market common stock offering program, including forward sale flexibility, while issuing 2026 guidance that points to higher net income and 7% to 11% total portfolio same-store NOI growth.
• Next, we’ll examine how this large new at-the-market equity program could reshape American Healthcare REIT’s investment narrative and outlook.

Uncover the next big thing with 30 elite penny stocks that balance risk and reward.

American Healthcare REIT Investment Narrative Recap

To own American Healthcare REIT, you need to believe in sustained demand for senior-focused healthcare real estate and the company’s ability to keep translating that into growing cash flows. The latest earnings and reduced impairments support that view, while the new US$1.75 billion at-the-market equity program, and the completed US$769.9 million issuance, slightly heighten near term dilution risk but do not fundamentally change the main catalyst of continued same store NOI growth.

The most relevant announcement here is the launch of the new US$1.75 billion at-the-market common stock offering, which immediately replaced a smaller, unused 2025 program and has already been tapped. For investors focused on American Healthcare REIT’s acquisition and development pipeline as a key growth driver, this sizeable equity program matters because it underpins funding capacity for new investments and balance sheet flexibility at the same time as management is guiding to 7% to 11% same store NOI growth in 2026.

But while growth funding is in place, investors should also be aware that...

American Healthcare REIT's narrative projects $2.7 billion revenue and $203.0 million earnings by 2028. This requires 7.8% yearly revenue growth and a $235.8 million earnings increase from $-32.8 million today.

Uncover how American Healthcare REIT's forecasts yield a $56.08 fair value, a 6% upside to its current price.

Exploring Other Perspectives

Three Simply Wall St Community fair value estimates for American Healthcare REIT span roughly US$39 to US$87 per share, showing how far apart individual views can be. Set against this wide range, the recent US$1.75 billion at-the-market program and ongoing reliance on acquisitions highlight why it is worth comparing several independent opinions on how external growth and dilution could affect future performance.

Explore 3 other fair value estimates on American Healthcare REIT - why the stock might be worth as much as 64% more than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your American Healthcare REIT research is our analysis highlighting 3 key rewards and 4 important warning signs that could impact your investment decision.
• Our free American Healthcare REIT research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate American Healthcare REIT's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Find 45 companies with promising cash flow potential yet trading below their fair value.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 22 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.